Is ORPHY or XYLD a better dividend investment in 2026?

ORPHY currently yields 6666.67% with a 5% 5-year dividend growth rate. XYLD yields 11.20% with 0.5% growth. The better choice depends on your goal: ORPHY offers higher current income.

What is the dividend yield difference between ORPHY and XYLD?

ORPHY has a forward dividend yield of 6666.67% ($2.00/share annually). XYLD yields 11.20% ($4.30/share annually). The yield gap is 6655.47 percentage points.

Home › Compare › ORPHY vs XYLD

ORPHY vs XYLD: Dividend Comparison 2026

ORPHY yields 6666.67% · XYLD yields 11.20%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ORPHY wins by $1028095347812062.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ORPHY

● Live price

6666.67%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1028095347812062.00M

Annual income

$998,628,545,336,266,700,000.00

Full ORPHY calculator →

XYLD

Global X S&P 500 Covered Call ETF

● Live price

11.20%

Share price

$38.36

Annual div

$4.30

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.9K

Annual income

$3,351.03

Full XYLD calculator →

Portfolio growth — ORPHY vs XYLD

📍 ORPHY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ORPHY	XYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ORPHY + XYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ORPHY pays

XYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ORPHY

Annual income on $10K today (after 15% tax)

$566,666.67/yr

After 10yr DRIP, annual income (after tax)

$848,834,263,535,826,600,000.00/yr

XYLD

Annual income on $10K today (after 15% tax)

$952.37/yr

After 10yr DRIP, annual income (after tax)

$2,848.38/yr

At 15% tax rate, ORPHY beats the other by $848,834,263,535,826,600,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ORPHY + XYLD for your $10,000?

ORPHY: 50%XYLD: 50%

100% XYLD50/50100% ORPHY

Portfolio after 10yr

$514047673906031.00M

Annual income

$499,314,272,668,133,360,000.00/yr

Blended yield

97.13%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ORPHY buys

XYLD buys

No recent congressional trades found for ORPHY or XYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricORPHYXYLD

Forward yield	6666.67% ✓	11.20%
Annual dividend / share	$2.00	$4.30 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1028095347812062.00M ✓	$25.9K
Annual income after 10y	$998,628,545,336,266,700,000.00 ✓	$3,351.03
Total dividends collected	$1026118102492338.88M ✓	$20.2K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: ORPHY vs XYLD ($10,000, DRIP)

Year	ORPHY Portfolio	ORPHY Income/yr	XYLD Portfolio	XYLD Income/yr	Gap
1← crossover	$677,367	$666,666.67	$10,840	$1,120.44	+$666.5K → ORPHY
2	$42,928,313	$42,203,530.63	$11,786	$1,249.59	+$42.92M → ORPHY
3	$2,545,616,701	$2,499,683,405.64	$12,854	$1,397.78	+$2545.60M → ORPHY
4	$141,255,910,403	$138,532,100,533.89	$14,063	$1,568.33	+$141255.90M → ORPHY
5	$7,335,374,338,812	$7,184,230,514,680.15	$15,434	$1,765.19	+$7335374.32M → ORPHY
6	$356,516,885,536,661	$348,668,034,994,132.70	$16,995	$1,993.14	+$356516885.52M → ORPHY
7	$16,218,956,689,966,618	$15,837,483,622,442,392.00	$18,777	$2,257.95	+$16218956689.95M → ORPHY
8	$690,711,023,145,868,900	$673,356,739,487,604,600.00	$20,818	$2,566.58	+$690711023145.85M → ORPHY
9	$27,539,067,734,387,980,000	$26,800,006,939,621,900,000.00	$23,163	$2,927.50	+$27539067734387.95M → ORPHY
10	$1,028,095,347,812,062,000,000	$998,628,545,336,266,700,000.00	$25,865	$3,351.03	+$1028095347812062.00M → ORPHY

ORPHY vs XYLD: Complete Analysis 2026

ORPHY — Stock

Orphazyme A/S, a biopharmaceutical company, develops therapies for the treatment of neurodegenerative rare diseases. The company offers heat stock proteins that focuses on the treatment of neurodegenerative diseases by harnessing the cell protective properties of the heat shock response, which protects cells from the accumulation of misfolded proteins, aggregated proteins, and dysfunctional lysosomes. Its lead candidate is the Arimoclomol, which is in clinical development for diseases, including Niemann-Pick disease type C, Amyotrophic Lateral Sclerosis, and Inclusion Body Myositis. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.

Full ORPHY Calculator →

XYLD — ETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →

📬

Get this ORPHY vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ORPHY vs SCHD ORPHY vs JEPI ORPHY vs O ORPHY vs KO ORPHY vs MAIN ORPHY vs QYLD ORPHY vs JEPQ ORPHY vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.